InsiderClue
Insiders · Profile

KAKKIS EMIL D

President & CEO at Ultragenyx Pharmaceutical · Chief Medical Officer at BIOMARIN PHARMACEUTICAL. Filing since 31 Oct 2006. CIK 0001248093

RARE Ultragenyx Pharmaceutical Inc. President & CEO · 29 trades BMRN BIOMARIN PHARMACEUTICAL INC Chief Medical Officer · 18 trades
Company
Date
Role
Action
Shares
Amount
Of holding
RARE Ultragenyx Pharmaceutical Inc.
2 Mar 2026
President & CEO
Sold at will
54,404
$1.24M
7.6%
RARE Ultragenyx Pharmaceutical Inc.
3 Mar 2025
President & CEO
Sold on a plan
73,434
$3.09M
10.3%
RARE Ultragenyx Pharmaceutical Inc.
28 Feb 2025
President & CEO
Sold on a plan
25,000
$1.06M
1.1%
RARE Ultragenyx Pharmaceutical Inc.
30 Dec 2024
President & CEO
Sold on a plan
11,727
$495.23K
0.5%
RARE Ultragenyx Pharmaceutical Inc.
10 Dec 2024
President & CEO
Sold on a plan
8,273
$413.65K
0.4%
RARE Ultragenyx Pharmaceutical Inc.
3 Sep 2024
President & CEO
Sold on a plan
20,000
$1.12M
0.9%
RARE Ultragenyx Pharmaceutical Inc.
6 Aug 2024
President & CEO
Sold on a plan
20,000
$1.00M
0.9%
RARE Ultragenyx Pharmaceutical Inc.
7 Feb 2024
President & CEO
Sold at will
30,000
$1.35M
5.3%
RARE Ultragenyx Pharmaceutical Inc.
29 Dec 2023
President & CEO
Sold at will
30,000
$1.44M
5.0%
RARE Ultragenyx Pharmaceutical Inc.
19 Oct 2023
President & CEO
Sold at will
47,853
$1.60M
7.4%
RARE Ultragenyx Pharmaceutical Inc.
30 Dec 2022
President & CEO
Sold, plan not stated
19,582
$892.35K
3.5%
RARE Ultragenyx Pharmaceutical Inc.
3 May 2021
President & CEO
Sold, plan not stated
30,000
$3.23M
1.3%
RARE Ultragenyx Pharmaceutical Inc.
1 Mar 2021
President & CEO
Sold, plan not stated
30,000
$4.25M
1.3%
RARE Ultragenyx Pharmaceutical Inc.
4 Jan 2021
President & CEO
Sold, plan not stated
30,000
$4.11M
1.3%
RARE Ultragenyx Pharmaceutical Inc.
2 Nov 2020
President & CEO
Sold, plan not stated
30,000
$2.90M
1.3%
RARE Ultragenyx Pharmaceutical Inc.
1 Sep 2020
President & CEO
Sold, plan not stated
30,000
$2.48M
1.2%
RARE Ultragenyx Pharmaceutical Inc.
13 Jul 2020
President & CEO
Sold, plan not stated
40,000
$3.41M
1.6%
RARE Ultragenyx Pharmaceutical Inc.
11 Sep 2019
President & CEO
Bought
5,000
$218.15K
1.1%
RARE Ultragenyx Pharmaceutical Inc.
28 Aug 2017
President & CEO
Bought
7,500
$393.92K
0.3%
RARE Ultragenyx Pharmaceutical Inc.
15 Nov 2016
President & CEO
Sold, plan not stated
20,000
$1.63M
4.3%
RARE Ultragenyx Pharmaceutical Inc.
14 Oct 2016
President & CEO
Sold, plan not stated
20,000
$1.26M
4.1%
RARE Ultragenyx Pharmaceutical Inc.
15 Aug 2016
President & CEO
Sold, plan not stated
20,000
$1.35M
3.9%
RARE Ultragenyx Pharmaceutical Inc.
15 Jul 2016
President & CEO
Sold, plan not stated
20,000
$1.02M
3.8%
RARE Ultragenyx Pharmaceutical Inc.
16 May 2016
President & CEO
Sold, plan not stated
20,000
$1.20M
3.7%
RARE Ultragenyx Pharmaceutical Inc.
15 Apr 2016
President & CEO
Sold, plan not stated
20,000
$1.41M
3.6%
RARE Ultragenyx Pharmaceutical Inc.
31 Dec 2015
President & CEO
Sold, plan not stated
5,498
$624.29K
0.9%
RARE Ultragenyx Pharmaceutical Inc.
30 Dec 2015
President & CEO
Sold, plan not stated
14,502
$1.67M
2.4%
RARE Ultragenyx Pharmaceutical Inc.
30 Nov 2015
President & CEO
Sold, plan not stated
20,000
$1.97M
3.2%
RARE Ultragenyx Pharmaceutical Inc.
30 Oct 2015
President & CEO
Sold, plan not stated
20,000
$1.99M
3.1%
BMRN BIOMARIN PHARMACEUTICAL INC
2 Mar 2009
Chief Medical Officer
Sold, plan not stated
7,897
$92.40K
16.6%
BMRN BIOMARIN PHARMACEUTICAL INC
3 Feb 2009
Chief Medical Officer
Sold, plan not stated
17,000
$325.37K
30.0%
BMRN BIOMARIN PHARMACEUTICAL INC
2 Jan 2009
Chief Medical officer
Sold, plan not stated
17,000
$298.69K
30.0%
BMRN BIOMARIN PHARMACEUTICAL INC
1 Dec 2008
CHIEF MEDICAL OFFICER
Sold, plan not stated
17,000
$269.79K
30.0%
BMRN BIOMARIN PHARMACEUTICAL INC
25 Nov 2008
Chief Medical Officer
Sold, plan not stated
75,000
$1.20M
65.4%
BMRN BIOMARIN PHARMACEUTICAL INC
31 Oct 2008
Chief Medical Officer
Bought
317
$4.23K
0.3%
BMRN BIOMARIN PHARMACEUTICAL INC
1 Oct 2008
Chief Medical Officer
Sold, plan not stated
18,000
$472.88K
13.5%
BMRN BIOMARIN PHARMACEUTICAL INC
2 Sep 2008
Chief Medical Officer
Sold, plan not stated
18,000
$543.38K
13.5%
BMRN BIOMARIN PHARMACEUTICAL INC
1 Aug 2008
Chief Medical Officer
Sold, plan not stated
18,000
$584.58K
12.4%
BMRN BIOMARIN PHARMACEUTICAL INC
7 Jul 2008
Chief Medical Officer
Sold, plan not stated
18,000
$505.08K
11.0%
BMRN BIOMARIN PHARMACEUTICAL INC
2 Jun 2008
Chief Medical Officer
Sold, plan not stated
18,000
$677.37K
10.1%
BMRN BIOMARIN PHARMACEUTICAL INC
1 May 2008
Chief Medical Officer
Sold, plan not stated
18,000
$674.86K
10.0%
BMRN BIOMARIN PHARMACEUTICAL INC
30 Apr 2008
Chief Medical Officer
Bought
1,640
$17.01K
1.0%
BMRN BIOMARIN PHARMACEUTICAL INC
1 Apr 2008
Chief Medical Officer
Sold, plan not stated
18,000
$644.96K
17.3%
BMRN BIOMARIN PHARMACEUTICAL INC
6 Mar 2008
Chief Medical Officer
Sold, plan not stated
18,000
$686.87K
17.3%
BMRN BIOMARIN PHARMACEUTICAL INC
31 Oct 2007
Chief Medical Officer
Bought
2,038
$14.10K
2.2%
BMRN BIOMARIN PHARMACEUTICAL INC
30 Apr 2007
Chief Medical Officer
Bought
2,982
$15.46K
3.3%
BMRN BIOMARIN PHARMACEUTICAL INC
31 Oct 2006
Chief Medical Officer
Bought
4,368
$15.00K
12.9%
47 decisions on file.